CA3102329C - Nouveaux anticorps anti-cd39 - Google Patents

Nouveaux anticorps anti-cd39

Info

Publication number
CA3102329C
CA3102329C CA3102329A CA3102329A CA3102329C CA 3102329 C CA3102329 C CA 3102329C CA 3102329 A CA3102329 A CA 3102329A CA 3102329 A CA3102329 A CA 3102329A CA 3102329 C CA3102329 C CA 3102329C
Authority
CA
Canada
Prior art keywords
seq
sequence
antibody
chain variable
variable region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3102329A
Other languages
English (en)
Other versions
CA3102329A1 (fr
Inventor
Yangsheng Qiu
Meiling Sun
Roumei XING
Dan Xu
Yufei Shi
Jinfeng Zhao
Qinglin DU
Zhihao Wu
Rui Gao
Robert H. ARCH
Hongtao Lu
Original Assignee
Elpiscience Biopharma Ltd
Elpiscience Suzhou Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elpiscience Biopharma Ltd, Elpiscience Suzhou Biopharma Ltd filed Critical Elpiscience Biopharma Ltd
Priority claimed from PCT/CN2020/111219 external-priority patent/WO2021037037A1/fr
Publication of CA3102329A1 publication Critical patent/CA3102329A1/fr
Application granted granted Critical
Publication of CA3102329C publication Critical patent/CA3102329C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente divulgation concerne des anticorps anti-CD39 ou des fragments de liaison de l’antigène connexe, des polynucléotides isolés les codant, des compositions pharmaceutiques les comprenant et leurs utilisations.
CA3102329A 2019-08-27 2020-08-26 Nouveaux anticorps anti-cd39 Active CA3102329C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2019/102778 2019-08-27
CN2019102778 2019-08-27
CN202010842863 2020-08-20
CN202010842863.9 2020-08-20
PCT/CN2020/111219 WO2021037037A1 (fr) 2019-08-27 2020-08-26 Nouveaux anticorps anti-cd39

Publications (2)

Publication Number Publication Date
CA3102329A1 CA3102329A1 (fr) 2021-02-27
CA3102329C true CA3102329C (fr) 2025-10-28

Family

ID=

Similar Documents

Publication Publication Date Title
TWI853077B (zh) 新型抗cd39抗體
JP7080213B2 (ja) 新規抗pd-l1抗体
CN112867507B (zh) 新型抗sirpa抗体
CN111484555B (zh) 新型双特异性cd3/cd20多肽复合物
CA3198102A1 (fr) Anticorps anti-dectine-1 et leurs methodes d'utilisation
WO2020168554A1 (fr) Fragment fc modifié, anticorps le comprenant et son application
US20230416394A1 (en) Novel conjugate molecules targeting cd39 and tgfbeta
CN109535253A (zh) 新型抗cd19抗体
CN110305214A (zh) 新型抗cd47抗体
CA3196930A1 (fr) Nouveaux anticorps anti-claudin18
CN113811545B (zh) 对btn2具有特异性的抗体及其用途
CA3102329C (fr) Nouveaux anticorps anti-cd39
CN119013301A (zh) 与epcam和/或cd137结合的结合剂
KR20240004694A (ko) 항체
HK40041672B (zh) 新型抗cd39抗体
HK40041672A (en) Novel anti-cd39 antibodies
HK40078567A (en) Novel conjugate molecules targeting cd39 and tgfβeta
HK40109194A (zh) 抗体
HK40045149A (en) Novel anti-sirpa antibodies
HK40032023B (en) A novel bispecific cd3/cd20 polypeptide complex
HK40013208A (en) Novel anti-cd47 antibodies